11/6
08:07 am
nrix
Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $29.00 price target on the stock.
Medium
Report
Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $29.00 price target on the stock.
11/6
06:07 am
nrix
Rating for NRIX
Medium
Report
Rating for NRIX
11/6
06:07 am
nrix
Rating for NRIX
Medium
Report
Rating for NRIX
10/24
07:44 am
nrix
Rating for NRIX
Low
Report
Rating for NRIX
10/24
07:16 am
nrix
Nurix Therapeutics, Inc. (NASDAQ: NRIX) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $35.00 price target on the stock.
Low
Report
Nurix Therapeutics, Inc. (NASDAQ: NRIX) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $35.00 price target on the stock.
10/21
08:07 am
nrix
Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $29.00 price target on the stock.
Low
Report
Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $29.00 price target on the stock.
10/21
07:13 am
nrix
Rating for NRIX
Low
Report
Rating for NRIX
10/21
07:13 am
nrix
Rating for NRIX
Low
Report
Rating for NRIX
10/14
09:41 am
nrix
Rating for NRIX
Medium
Report
Rating for NRIX
10/14
09:41 am
nrix
Rating for NRIX
Medium
Report
Rating for NRIX
10/14
09:09 am
nrix
Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $31.00 price target on the stock.
Medium
Report
Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $31.00 price target on the stock.
10/14
09:09 am
nrix
Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $31.00 price target on the stock.
Medium
Report
Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $31.00 price target on the stock.
10/14
09:00 am
nrix
Rating for NRIX
Medium
Report
Rating for NRIX
10/14
08:41 am
nrix
Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $29.00 price target on the stock.
Medium
Report
Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $29.00 price target on the stock.
10/14
06:46 am
nrix
Rating for NRIX
Low
Report
Rating for NRIX
10/14
06:46 am
nrix
Rating for NRIX
Low
Report
Rating for NRIX
10/11
08:01 am
nrix
Rating for NRIX
Medium
Report
Rating for NRIX
10/11
08:01 am
nrix
Rating for NRIX
Medium
Report
Rating for NRIX
9/6
09:00 am
nrix
Nurix Therapeutics, Inc. (NASDAQ: NRIX) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $26.00 price target on the stock.
Medium
Report
Nurix Therapeutics, Inc. (NASDAQ: NRIX) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $26.00 price target on the stock.
9/4
12:59 pm
nrix
Rating for NRIX
Low
Report
Rating for NRIX
9/4
12:59 pm
nrix
Rating for NRIX
Low
Report
Rating for NRIX